Search

What The Current Research Reveals About Utilizing Amnion/Chorion Allografts For Diabetic Foot Ulcers

Charles M. Zelen, DPM, FACFAS, and Thomas Serena, MD | 1,347 reads | 0 comments | 06/19/2017

A Closer Look At The Newest Cellular Therapy For Diabetic Foot Ulcers

Barbara Aung DPM | 3,332 reads | 0 comments | 08/24/2016

Until recently, there had not been a new product introduced in the wound care arena that had gone through the Food and Drug Administration (FDA) approval process in several years. The FDA recently announced the approval of the Omnigraft Dermal Regeneration Matrix (Integra LifeSciences) for its new indication in the treatment of diabetic foot ulcers in the outpatient clinical setting.

Point-Counterpoint: Is Tendon Lengthening A Worthwhile Treatment For Diabetic Forefoot Ulcers?

J. Monroe Laborde, MD, MS, and Richard D. Weiner, DPM | 2,743 reads | 0 comments | 09/22/2016
Yes.

This author notes that when one combines Achilles tendon lengthening with other treatments for the diabetic foot, it can help heal lower extremity wounds and prevent wound recurrence and amputation.     

By J. Monroe Laborde, MD, MS

Treating Diabetic Foot Ulcers Like An Aggressive Cancer

David G. Armstrong DPM MD PhD | 3,405 reads | 0 comments | 01/01/2016

When we tackle the problem of diabetic foot ulcers, the idea is not just the mortality. The idea is that diabetes is like cancer but we do not tend to treat diabetes like cancer and we should be. We should be communicating and using the same language in terms of morbidity and mortality as we do with cancer. When we look at the data from a new study, the mortality rate is similar to the rate of very aggressive cancer.1

Could Micro-Autografts Have Potential In Healing Diabetic Foot Ulcers?

Wayne J. Caputo, DPM, FACFAS, and George J. Fahoury, DPM, FACFAS | 3,401 reads | 0 comments | 02/22/2016

The goal of wound management is to attain cost effective wound closure to reestablish function.1 This is especially true with lower extremity wounds that are debilitating and often lead to a temporary or permanent disability.

Does Continuous Diffusion Of Oxygen Have Potential In Chronic Diabetic Foot Ulcers?

Mark Couture, DPM | 3,376 reads | 0 comments | 11/19/2015

Chronic wounds, typically defined as wounds that have not decreased in size by 50 percent after four to six weeks of treatment, are often accompanied by complications including peripheral neuropathy, diabetes, peripheral vascular disease (PVD) and poor patient adherence.1-4

Emphasizing Prevention Strategies To Reduce The Economic Burden Of Diabetic Foot Complications

David G. Armstrong DPM MD PhD | 2,274 reads | 0 comments | 03/23/2016

Diabetic foot ulcers cost over $15 billion a year in the United States and a recent study seeks some solutions to relieve the economic burden.1,2

Examining The Potential Of Collagen Powders In The Diabetic Foot

Jonathan Moore, DPM, MS, MA | 12,065 reads | 0 comments | 04/20/2015

Offloading A Diabetic Foot Ulcer In The Developing World

Lakshmi K. Shankhdhar, MD, PGDND, DMRE, MAMS, FICN, FHMI (Boston), Kshitij Shankhdhar, MBBS, Dip Diab, MD, FICN, FAPWCA (USA), Uma Shankhdhar, MBBS, DND, DDM, and Smita Shankhdhar, MBBS, MUPMA, MICN | 5,403 reads | 0 comments | 09/23/2015

At one point, limb loss due to diabetes occurred every 30 seconds. Recent research has reduced the figure to every 20 seconds.1-3 Eighty-five percent of lower limb amputations follow incidence of a diabetic foot ulcer and most are preventable.4,5

A Closer Look At The Potential Of Placental Membrane Grafts For Chronic Diabetic Foot Ulcerations

Sarah Abshier, DPM, CWS | 9,940 reads | 0 comments | 10/23/2015

The treatment of chronic diabetic foot ulcers is a challenging endeavor. Fortunately, medical advances continue to provide promising new technologies to aid physicians in healing difficult wounds. The properties and composition of placental membranes make them a very powerful tool in wound care as placental membranes address the unique myriad needs of chronic diabetic foot ulcers (DFUs).